advanc
medicin
centuri
along
age
popul
chang
lifestyl
alter
natur
diseas
reform
econom
issu
major
concern
deng
xiaop
advoc
notion
scienc
technolog
constitut
primari
product
forc
nation
hightechnolog
programm
launch
biotechnolog
main
prioriti
sinc
china
use
scienc
educ
improv
intern
competit
increas
expenditur
research
develop
gross
domest
product
gdp
period
annual
rate
growth
gdp
reach
time
china
set
polici
develop
talent
pool
biomed
research
rank
fourth
intern
patent
grant
public
index
journal
govern
research
develop
budget
spent
life
scienc
biotechnolog
includ
healthrel
domain
encourag
investigatoriniti
project
augment
budget
nation
natur
scienc
foundat
fi
vefold
increas
past
decad
rise
billion
renminbi
billion
china
also
launch
nation
key
basic
research
programm
establish
major
scientifi
c
facil
includ
synchrotron
lightsourc
centr
genom
protein
scienc
drug
screen
biodivers
conserv
combin
resourc
human
genet
tradit
chines
western
medicin
comprehens
medic
research
system
develop
addit
contribut
sequenc
human
genom
hapmap
project
scientist
sequenc
genom
sever
import
speci
includ
rice
chicken
domest
silkmoth
schistosoma
japonicum
molecular
pathogenesi
infecti
outbreak
sever
acut
respiratori
syndrom
sar
avian
infl
uenza
sever
chronic
diseas
also
analys
develop
select
diff
erenti
apoptosi
induct
acut
promyelocyt
leukaemia
exampl
function
genom
promot
target
cancer
therapi
china
join
intern
research
eff
ort
proteom
structur
genom
crystal
structur
sever
protein
complex
includ
mitochondri
respiratori
chain
complex
ii
characteris
fi
rst
human
proteom
catalogu
liver
gener
advanc
domain
also
madeeg
eff
ect
lymphoid
microenviron
dendrit
cell
signal
transduct
involv
arrestin
regul
gproteincoupl
receptor
signal
biochip
appli
clinic
medicin
food
safeti
china
fi
rst
countri
issu
approv
govern
regul
state
food
drug
administr
sfda
use
biochip
screen
diseas
hepat
c
china
approv
world
fi
rst
genetherapi
product
recombin
human
serotyp
adenoviru
gendicin
tumour
suppressor
almost
new
drug
either
introduc
market
latephas
clinic
trial
analogu
artemisinin
key
compon
combin
therapi
malaria
recommend
quicktest
diagnost
reagent
hivaid
especi
noteworthi
achiev
vaccin
sar
avian
infl
uenza
establish
import
platform
antibodi
studi
stemcel
research
patent
set
standard
anim
clone
gener
human
embryon
stemcel
line
nuclear
transfer
somat
cell
somat
stemcel
isol
characteris
expans
direct
diff
erenti
stem
progenitor
cell
tissu
organ
engin
exampl
use
mesenchym
stem
cell
support
haemopoiesi
bonemarrow
transplant
clinic
trial
sfda
recent
ratifi
ed
certifi
cate
novel
artifi
cial
skin
yet
china
face
sever
challeng
includ
need
develop
sound
infrastructur
healthcar
insur
lack
eff
ectiv
partnership
academ
industri
sector
insuffi
cient
invest
drug
research
develop
unsatisfactori
support
oversight
food
drug
safeti
move
toward
outlook
scientifi
c
develop
aim
develop
equit
societi
china
place
public
health
top
agenda
aim
health
present
countri
concentr
primari
health
care
rural
area
commun
medicin
citi
initi
goal
framework
deliveri
health
care
insur
system
cover
peopl
government
fund
take
lead
end
new
rural
cooper
medicar
scheme
contribut
public
coff
er
cover
million
farmer
china
new
initi
cover
urban
citizen
also
launch
use
biomedicin
boost
access
equal
provis
health
care
strategi
walk
two
leg
advoc
strategi
suggest
excel
cuttingedg
technolog
pursu
along
serveal
approach
guidelin
nation
mediumand
longterm
program
develop
develop
drug
innov
prevent
control
major
emerg
infecti
diseas
list
two
mega
project
line
notion
predict
preven
tive
personalis
participatori
medicin
diseas
prevent
prioriti
import
attach
provis
clean
drink
water
environ
mental
health
natur
disast
disast
prepar
ness
largescal
product
goodqual
food
drug
vaccin
product
regul
product
reliabl
reagent
diagnosi
screen
devel
op
ment
ehealthcar
system
manag
chronic
noncommunic
diseas
moreov
modern
isat
tradit
chines
medicin
strengthen
multicentr
clinic
trial
evalu
effi
caci
implement
standardis
qualiti
control
also
studi
system
biomedicin
china
translat
research
capac
improv
combin
clinic
resourc
research
strength
creat
environ
consid
ethic
legal
societ
input
encourag
indigen
innov
china
need
extend
intern
collabor
person
exchang
joint
project
believ
factor
contribut
improv
public
health
centuri
minist
health
ministri
health
beij
china
rui
jin
hospit
shanghai
china
zchen
stnshcn
comment
benefi
ted
consider
construct
discuss
zhan
qimin
chines
academi
medic
scienc
declar
confl
ict
interest
